UNSPSC 51282427: Ticarcillin disodium

This classification denotes an extended spectrum penicillin antibiotic with the molecular formula C15H14N2O6S2.2Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier G8TVV6DSYG, chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((carboxy-3-thienylacetyl)amino)-3,3-dimethyl-7-oxo-, disodium salt, (2s-(2alpha,5alpha,6beta(s*)))- but more generally known as ticarcillin disodium, which bears US NIH Compound Identifier 20823.

UNSPSC 51282427 Ticarcillin disodium is a Commodity code for a specific injectable antibiotic, yet recent state and local procurement activity tagged under this code shows minimal alignment with the pharmaceutical product itself. The code sees sporadic activity across health and human services agencies, but the recent opportunities—including naloxone procurement, direct-to-manufacturer pharmacy initiatives, emergency medical supplies, and multi-source generic pharmaceuticals—reflect broader pharmaceutical and health supply procurement rather than ticarcillin-specific demand. State and local governments use related UNSPSC codes to solicit injectable antibiotics, over-the-counter pharmaceuticals, emergency medical supplies, and pharmacy benefit management services through health departments, county health systems, municipal fire departments, and cooperative purchasing alliances.

The Texas Health and Human Services Commission issued a Request for Information (RFI HHS0017013) in April 2026 to explore direct-to-manufacturer prescription programs; the City of Tampa Purchasing Department issued an IFB (26P00145) in March 2026 for medical and first aid supplies ($700,000 estimated contract value, sheltered for certified Small Local Business Enterprises) to the Tampa Fire Department Rescue Division; Seminole County, Florida issued an IFB (IFB60459723LAS) in June 2026 for naloxone and drug deactivation systems with quarterly deliveries; and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued an RFP (S1070000015802) in January 2026 for generic multi-source pharmaceuticals and OTC products, with responses due March 26, 2026, and contract effectiveness July 1, 2026. Activity appears concentrated in Florida and Minnesota, with Texas exploratory procurement. This code warrants close watch only if your firm manufactures or distributes ticarcillin disodium specifically; broader antibiotic and pharmaceutical procurement sits in adjacent UNSPSC codes with more robust state and local demand signals.